We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Reduction of BRCA1 Induced by Sevoflurane Exacerbates the Neurotoxicity of Amyloid-β

    Abstract

    Inhaled anesthetic sevoflurane is widely reported to induce neurotoxicity, whereas the underlying mechanism is less elucidated. Here, we...

    Zhenghua Wu, Kuan Huang in Neurochemical Journal
    Article 01 March 2024
  2. GlyT1 Inhibition by NFPS Promotes Neuroprotection in Amyloid-β-Induced Alzheimer’s Disease Animal Model

    Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid-β, leading to N-methyl-D-aspartate (NMDA)...

    Onésia Cristina Oliveira-Lima, Gustavo Almeida de Carvalho, ... Mauro Cunha Xavier Pinto in Neurochemical Research
    Article 18 June 2024
  3. Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy

    Background

    Clinicians, researchers, and patients alike would greatly benefit from more accessible and inexpensive biomarkers for neural β-amyloid...

    Kazuto Yamashita, Masahiro Miura, ... Atsushi Iwata in Alzheimer's Research & Therapy
    Article Open access 23 June 2022
  4. Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies

    Dementia with Lewy bodies (DLB) is a neurodegenerative condition often co-occurring with Alzheimer’s disease (AD) pathology. Characterizing white...

    Elijah Mak, Robert I. Reid, ... Kejal Kantarci in npj Parkinson's Disease
    Article Open access 03 April 2024
  5. Association between retinal microvascular abnormalities and late-life brain amyloid-β deposition: the ARIC-PET study

    Background

    Retinal microvascular signs are accessible measures of early alterations in microvascular dysregulation and have been associated with...

    Marco Egle, Jennifer A. Deal, ... Rebecca F. Gottesman in Alzheimer's Research & Therapy
    Article Open access 06 May 2024
  6. Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology

    Aging is the main risk factor for Alzheimer’s disease (AD) and other neurodegenerative pathologies, but the molecular and cellular changes underlying...

    Nuria Suelves, Shirine Saleki, ... Pascal Kienlen-Campard in Acta Neuropathologica Communications
    Article Open access 17 May 2023
  7. Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

    Background

    Regulatory T cells (Tregs) maintain immune tolerance. While Treg-mediated neuroprotective activities are now well-accepted, the lack of...

    Pravin Yeapuri, Jatin Machhi, ... Howard E. Gendelman in Molecular Neurodegeneration
    Article Open access 18 December 2023
  8. Neuroprotective role of nobiletin against amyloid-β (Aβ) aggregation in Parkinson and Alzheimer disease as neurodegenerative diseases of brain

    The presence of neuronal amyloid β (Aβ) plaques and neurofibrillary tangles are the main indicators of Alzheimer’s disease (AD) and Parkinson’s...

    Vahid Alivirdiloo, Mobasher Hajiabbasi, ... Amin mehra in Medicinal Chemistry Research
    Article 07 June 2024
  9. Continuity of care (COC) and amyloid-β PET scan: the CARE-IDEAS study

    Background

    High continuity of care (COC) is associated with better clinical outcomes among older adults. The impact of amyloid-β PET scan on COC among...

    Emily C. O’Brien, Cassie B. Ford, ... Courtney Van Houtven in Alzheimer's Research & Therapy
    Article Open access 07 January 2023
  10. Amyloid β oligomer induces cerebral vasculopathy via pericyte-mediated endothelial dysfunction

    Background

    Although abnormal accumulation of amyloid beta (Aβ) protein is thought to be the main cause of Alzheimer’s disease (AD), emerging evidence...

    Siqi Chen, Daji Guo, ... Yamei Tang in Alzheimer's Research & Therapy
    Article Open access 12 March 2024
  11. β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer’s disease model mice

    Extensive studies indicate that β-amyloid (Aβ) aggregation is pivotal for Alzheimer’s disease (AD) progression; however, cumulative evidence suggests...

    Yini Zhao, Qiuyang Zheng, ... **n Wang in Nature Neuroscience
    Article 01 June 2023
  12. Amyloid PET Imaging: Standard Procedures and Semiquantification

    Amyloid plaques are a neuropathologic hallmark of Alzheimer’s disease (AD), which can be imaged through positron emission tomography (PET) technology...
    Francesca D’Amico, Luca Sofia, ... Silvia Morbelli in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  13. Amyloid-β in Brain Aging and Alzheimer’s Disease

    During aging, the brain milieu changes in a multitude of ways, resulting in a decline of physiological functions and increased susceptibility to...
    Hiroki Sasaguri, Takaomi C. Saido in Aging Mechanisms II
    Chapter 2022
  14. Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals

    Background

    Cortical deposition of β-amyloid (Aβ) plaque is one of the main hallmarks of Alzheimer’s disease (AD). While Aβ positivity has been the...

    Chae Jung Park, Younghoon Seo, ... Jun Pyo Kim in Alzheimer's Research & Therapy
    Article Open access 12 September 2022
  15. The Role of JNK and p53 in the Regulation of Secretory Function of Neuroglial Cells of Various Types in β-Amyloid-Induced Neurodegeneration

    We studied the effect of JNK and p53 inhibitors on the production of neurotrophic factors stimulating the realization of the growth potential of...

    G. N. Zyuz’kov, L. A. Miroshnichenko, ... L. Yu. Kotlovskaya in Bulletin of Experimental Biology and Medicine
    Article 01 October 2023
  16. Near-infrared fluorescence lifetime imaging of amyloid-β aggregates and tau fibrils through the intact skull of mice

    Non-invasive methods for the in vivo detection of hallmarks of Alzheimer’s disease can facilitate the study of the progression of the disease in...

    Steven S. Hou, Joyce Yang, ... Hak Soo Choi in Nature Biomedical Engineering
    Article 06 February 2023
  17. Natural IgG antibodies to β amyloid are decreased in patients with Parkinson’s disease

    Natural antibodies (nAbs) against aggregation-prone proteins have been found in healthy normal subjects. These proteins likely have a pathogenetic...

    Roberto Paganelli, Alessia Paganelli, ... Angelo Di Iorio in Immunity & Ageing
    Article Open access 11 March 2023
  18. Functional State of Various Types of Regenerative-Competent Neural Tissue Cells in β-Amyloid-Induced Neurodegeneration

    We analyzed the content and functional activity of various types of regenerative-competent cells of the subventricular zone of the cerebral...

    G. N. Zyuz’kov, L. A. Miroshnichenko, ... L. Yu. Kotlovskaya in Bulletin of Experimental Biology and Medicine
    Article 01 October 2022
  19. Sex-Specific Entorhinal Cortex Functional Connectivity in Cognitively Normal Older Adults with Amyloid-β Pathology

    Sex and apolipoprotein E (APOE) genotype have been shown to influence the risk and progression of Alzheimer’s disease (AD). However, the impact of...

    Liang Gong, Duan Liu, ... Chunhua ** in Molecular Neurobiology
    Article Open access 13 June 2024
  20. LOTUS suppresses amyloid β-induced dendritic spine elimination through the blockade of amyloid β binding to PirB

    Background

    Alzheimer’s disease (AD) is the most common neurodegenerative disease worldwide but has no effective treatment. Amyloid beta (Aβ) protein,...

    Yuki Kawaguchi, Junpei Matsubayashi, ... Kohtaro Takei in Molecular Medicine
    Article Open access 12 December 2022
Did you find what you were looking for? Share feedback.